T‐antigen. A prognostic indicator of high recurrence index in transitional carcinoma of the bladder

Cancer

Volumn 61, Issue 6, 1988, Pages 1091-1095

  Blasco, Eduardo ^a   Torrado, Julio ^a,b,c   Belloso, Luis ^a   Arocena, Fernando ^a   Gutierrez‐Hoyos, Ariel ^a,b,c   Cuadrado, Emilio ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Universidad del Pais Vasco ^*  (Spain)

^c Unidad Docente de Medicina de San Sebastiá n   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; SIALIDASE;

BLADDER CARCINOMA; CIRCULATING ANTIBODY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ANTIGENS, VIRAL, TUMOR; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; HUMAN; ISOANTIGENS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0023837961     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880315)61:6<1091::AID-CNCR2820610607>3.0.CO;2-F     Document Type: Article

References (34)

1. Blood group glycolipid antigens and their modifications as human cancer antigens
2. Demonstration by monoclonal antibodies that carbohydrate structure of glycoproteins and glycolipids are onco‐developmental antigens
3. Isoantígenos sanguineos; Su interés en la oncogénesis y diferenciación celular
4. ABO antigens in cancer: Detection with the mixed cell agglutination reaction
5. Antigenis deletion and prognosis of patients with stage A transitional cell bladder carcinoma
6. The cell surface antigen A, B or O(H) as indicator of malignant potential in stage A bladder carcinoma
7. ABH antigens in transitional cell tumors of the urinary bladder: Correlation with the clinical course
8. ABH isoantigens in stage O papillary transitional cell carcinoma of the bladder: Correlation with biological behaviour
9. Monoclonal antibodies to detect ABH blood group isoantigens in superficial transitional cell carcinoma of the bladder: A means of predicting invasive recurrences
10. Blood group isoantigens ABO(H) in transitional carcinoma of the bladder: A clinicopathological study
11. Blood group precursor T antigen expression in human urinary bladder carcinoma
12. Peanut lectin binding sites in transitional cell carcinoma of the urinary bladder
13. Lewis a antigen in transitional cell tumors of the urinary bladder
14. Detection of urothelial Lewis antigens with monoclonal antibodies
15. Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastasis
16. Tumors of the urinary bladder
17. Fluorescent staining of nuclei and amyloid substance: Two useful properties of p‐Phenilendiamine
18. Carcinoms associated blood group MN precursor antigens against which all humans possess antibodies
19. Expression of Lewis a, Lewis b, X and Y blood group antigens in human colonic tumors and normal tissue and in human tumor derived cell lines
20. Immunologic study of blood group substances in recto colon diseases
21. Status of blood group carbohydrate chains in ontogenesis and oncogenesis
22. Specific antigens in serum of patients with colon carcinoma
23. A monoclonal antibody defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto N‐Fucopentaose II
24. Decreased levels of circulating lytic anti T in the serum of patients with metastatic gastrointestinal cancer: A correlation with disease burden
25. Glycolipids of gastric cancer: The presence of blood group A active glycolipids in cancer tissues from blood group O patients
26. Incompatible A antigen expressed in tumors of blood group O individuals: Immuno‐histologic and enzymatic characterization
27. Recent studies of glycolipid and glycoprotein profiles and characterization of the major glycolipid antigen in gastric cancer of a patient of blood group genotype pp (Tj a‐) first studied in 1951
28. Blood group isoantigen detection in carcinoma in situ of the urinary bladder
29. Surface glycoprotein from a mouse tumor cell as specific inhibitor of anti human blood group N agglutinin
30. Cross reacting carcinoma associated antigens with blood group and precursor specificities
31. Precursors of the blood group MN antigens as human carcinoma associated antigens
32. Flow cytometry: Role in monitoring transitional cell carcinoma of the bladder